Eli Lilly and Company | NYSE:LLY - Fraywire Market Portal
⚡ Login to use Pulse AI
Simple Chart
Advanced Chart
Login for Volatility Chart


Eli Lilly and Company on Glideslope

News aggregated by Glideslope.ai
September 18, 2025
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from SURPASS-PEDS, the first Phase 3 trial evaluating the safety and efficacy ...
September 12, 2025
Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medication: pills.
September 9, 2025
(RTTNews) - Eli Lilly and Company (LLY) has launched Brain Health Matters, a global initiative encouraging proactive steps to support brain h...
August 19, 2025
The results could reinforce Eli Lilly and Novo Nordisk's dominance in the booming market for weight loss and diabetes drugs.
August 7, 2025
Here are some of the stocks posting the biggest moves in midday trading.
August 7, 2025
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72...
June 29, 2025
When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential ...
June 22, 2025
(RTTNews) - Eli Lilly And Co.'s (LLY) investigational oral GLP-1 receptor agonist, orforglipron, demonstrated compelling efficacy and a ...
May 21, 2025
Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
May 15, 2025
(RTTNews) - Eli Lilly And Co. (LLY) will participate in the Bank of America Securities 2025 Healthcare Conference.